Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > LLY Eli Lilly and Co > Detailed Quotes

LLY Eli Lilly and Co

Watchlist
327.050
-2.960-0.90%
Trading Session 09/30 12:43 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
329.507
Open
327.150
Turnover
513.76M
Low
322.420
Pre Close
330.010
Volume
1.58M
Market Cap
310.75B
P/E(TTM)
52.16
52wk High
341.700
Shares
950.17M
P/E(Static)
53.44
52wk Low
221.092
Float Cap
295.90B
Bid/Ask %
0.00%
Historical High
341.700
Shs Float
904.76M
Volume Ratio
0.65
Historical Low
17.544
Dividend TTM
3.66
Div Yield TTM
3.4
P/B
36.37
Dividend LFY
1.12%
Div Yield LFY
1.04%
Turnover Ratio
0.18%
Amplitude
2.15%
Avg Price
325.196
Lot Size
1
Float Cap
295.90B
Bid/Ask %
0.00%
Historical High
341.700
Shs Float
904.76M
Volume Ratio
0.65
Historical Low
17.544
Dividend TTM
3.66
P/B
36.37
Dividend LFY
1.12%
Turnover Ratio
0.18%
Amplitude
2.15%
Avg Price
325.196
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin’s lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
CEO: Ricks, David A.
Market: NYSE
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top